Episodic status migrainosus: A novel migraine subtype

被引:14
|
作者
Singh, Tarun D. [1 ,2 ]
Cutrer, F. Michael [1 ]
Smith, Jonathan H. [2 ]
机构
[1] Mayo Clin, Dept Neurol, Rochester, MN USA
[2] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA
关键词
Migraine; status migrainosus; episodic status migrainosus; chronic migraine; headache; depression; TERTIARY-CARE; PREVALENCE; OSMOPHOBIA; DISEASE; BURDEN;
D O I
10.1177/0333102416686341
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To report a case series of a novel migraine subtype, which we term as episodic status migrainosus (ESM), characterized by attacks of migraine exclusively lasting more than 72 hours. We hypothesized that this would represent a novel nosologic entity, possibly an unstable migraine phenotype with a high conversion rate to chronic migraine (CM). Methods We conducted a retrospective review of patients diagnosed with status migrainosus at the Mayo Clinic, Rochester, between January 2005 and December 2015. All the records were then manually reviewed for patients with migraine headaches exclusively lasting more than 72 hours. Results We identified 18 patients with ESM, with a female predominance (15(83.3%)) and a median age of onset of 16.5 (IQR 13-19) years. The median monthly attack frequency was two (IQR 1-3), with each attack lasting a median duration of seven (IQR 4-12.5) days. Stress was the most commonly reported precipitant (11 (61.1%)). Migraine with aura was common (10 (55.6%)), as was comorbid depression (10 (55.6%)). Fifteen (83.3%) patients developed CM at a median of 7.8 (IQR 2.6-21.9) years from their first attack. There was no significant association between the time to the development of chronic migraine with either attack frequency or duration. Conclusions and relevance We report the existence of a novel migraine subtype, episodic status migrainosus. This migraine subtype appears to have similar clinical characteristics to episodic migraine with or without aura, except for a notably high tendency to progress to chronic migraine.
引用
下载
收藏
页码:304 / 311
页数:8
相关论文
共 50 条
  • [31] STATUS MIGRAINOSUS - CAUSATIVE AND THERAPEUTIC ASPECTS
    COUCH, JR
    DIAMOND, S
    HEADACHE, 1983, 23 (03): : 94 - 101
  • [32] Role of intravenous levetiracetam in status migrainosus
    Muhammad U. Farooq
    Arshad Majid
    Joseph J. Pysh
    Mounzer Y. Kassab
    The Journal of Headache and Pain, 2007, 8 (2) : 143 - 144
  • [33] Status migrainosus and Adie's syndrome
    Jacome, DE
    HEADACHE, 2002, 42 (08): : 793 - 795
  • [34] Treatment of status migrainosus with local anaesthetics
    Inan, L. E.
    Unal-Artik, H. A.
    Atac-Ucar, C.
    Inan, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 288 - 288
  • [35] Long Lasting Autonomic Symptoms with Hemicrania (LASH) Associated with Chronic Migraine and Recurrent Status Migrainosus - a Case Report
    Lozano, L.
    Montoya, L.
    Arango, E.
    Volcy Gomez, M.
    HEADACHE, 2018, 58 : 147 - 148
  • [36] Risk and Predisposing Factors for Suicide Attempts in Patients with Migraine and Status Migrainosus: A Nationwide Population-Based Study
    Harnod, Tomor
    Lin, Cheng-Li
    Kao, Chia-Hung
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (09):
  • [37] Prolonged status migrainosus complicated by cerebellar infarction
    Cure, Joel
    Rothrock, John
    HEADACHE, 2007, 47 (07): : 1091 - 1092
  • [38] Status migrainosus: Prevalence, associations and economic implications
    Weibelt, S. M.
    Rothrock, D. A.
    Rothrock, J. F.
    HEADACHE, 2008, 48 : S26 - S26
  • [39] Erenumab for episodic migraine
    Datta, Abhigyan
    Gupta, Sahil
    Maryala, Shashi
    Aggarwal, Vikram
    Chopra, Pooja
    Jain, Sameer
    PAIN MANAGEMENT, 2022, 12 (05) : 587 - 594
  • [40] Episodic Migraine and POTS
    Mueller, Bridget
    CURRENT PAIN AND HEADACHE REPORTS, 2023, 27 (11) : 757 - 763